<DOC>
	<DOCNO>NCT01896583</DOCNO>
	<brief_summary>This trial evaluate effect ASP7147 daily abdominal pain due IBS-D 4 week treatment . It also evaluate safety tolerability patient IBS-D 4-week treatment period .</brief_summary>
	<brief_title>A Phase 2 Pilot Study Assess ASP7147 Patients With Diarrhea Predominant Irritable Bowel Syndrome ( IBS-D )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Ability provide write informed consent Men woman age 1875 year Patient IBS diarrhea ( IBSD ) Ability communicate investigator IBS constipation ( IBSC ) mix IBS ( IBSM ) Other significant disease condition may interfere trial completion Untreated lactose intolerance History alcohol drug abuse past two year Participation clinical trial within prior month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>